4//SEC Filing
Leonard Frank X 4
Accession 0001562180-24-007516
CIK 0001645113other
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 4:34 PM ET
Size
10.4 KB
Accession
0001562180-24-007516
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Leonard Frank X
EVP, Pres., Novocure Oncology
Transactions
- Sale
Ordinary Shares
2024-11-01$15.94/sh−598$9,531→ 161,236 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]This transaction was executed in multiple trades at prices ranging from $15.88 USD to $15.9603 USD; the price reported above reflects the weighted average sale price.
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001822879
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 7:00 PM ET
- Accepted
- Nov 4, 4:34 PM ET
- Size
- 10.4 KB